Polyomavirus infection of renal allograft recipients: from latent infection to manifest disease.
about
Human polyomavirus reactivation: disease pathogenesis and treatment approachesBK polyoma virus infection and renal disease in non-renal solid organ transplantationDifferent behaviour of BK-virus infection in liver transplant recipientsClinical immune-monitoring strategies for predicting infection risk in solid organ transplantationA Structure-Guided Mutation in the Major Capsid Protein Retargets BK PolyomavirusFrequent detection of polyomaviruses in stool samples from hospitalized children.Tacrolimus Blood Level Fluctuation Predisposes to Coexisting BK Virus Nephropathy and Acute Allograft RejectionCross-reactivity of T lymphocytes recognizing a human cytotoxic T-lymphocyte epitope within BK and JC virus VP1 polypeptides.Involvement of cytoskeletal components in BK virus infectious entry.Ureteral Stent Placement Increases the Risk for Developing BK Viremia after Kidney TransplantationValidation of noninvasive diagnosis of BK virus nephropathy and identification of prognostic biomarkers.Functional reorganization of promyelocytic leukemia nuclear bodies during BK virus infection.The rapidly expanding family of human polyomaviruses: recent developments in understanding their life cycle and role in human pathology.Identification of species-specific and cross-reactive epitopes in human polyomavirus capsids using monoclonal antibodies.BK viremia and polyomavirus nephropathy in 352 kidney transplants; risk factors and potential role of mTOR inhibition.Immunoglobulin G, A, and M responses to BK virus in renal transplantation.Reevaluating and optimizing polyomavirus BK and JC real-time PCR assays to detect rare sequence polymorphisms.BK Virus in Kidney Transplant Recipients: The Influence of Immunosuppression.Review article: BK virus in systemic lupus erythematosusAdaptive immunity rather than viral cytopathology mediates polyomavirus-associated nephropathy in mice.Urine cytology screening for polyoma virus infection following renal transplantation: the Oxford experienceProgression from Sustained BK Viruria to Sustained BK Viremia with Immunosuppression Reduction Is Not Associated with Changes in the Noncoding Control Region of the BK Virus Genome.Human BK Polyomavirus-The Potential for Head and Neck Malignancy and DiseaseIdentification of amino acid residues in BK virus VP1 that are critical for viability and growth.Clinical and pathological features of kidney transplant patients with concurrent polyomavirus nephropathy and rejection-associated endarteritis.Molecular networks involved in the immune control of BK polyomavirus.Polyomavirus BK with rearranged noncoding control region emerge in vivo in renal transplant patients and increase viral replication and cytopathology.BK polyomavirus: emerging pathogen.Modeling Immune Response to BK Virus Infection and Donor Kidney in Renal Transplant Recipients.Clinical significance of quantitative and qualitative detection of BK and JC virus in blood and urine of renal transplantation recipients.Nonhuman primate infections after organ transplantation.longitudinal analysis of levels of immunoglobulins against BK virus capsid proteins in kidney transplant recipientsQuantitation of BK virus DNA for diagnosis of BK virus-associated nephropathy in renal transplant recipients.Presence of urinary Haufen accurately predicts polyomavirus nephropathy.Risk factors for polyoma virus nephropathyAntibody responses to recombinant polyomavirus BK large T and VP1 proteins in young kidney transplant patients.Antirejection treatment in kidney transplant patients with BK viruria.Opportunistic infections (non-cytomegalovirus) in live related renal transplant recipients.Infection of vero cells by BK virus is dependent on caveolae.Transient versus persistent BK viremia and long-term outcomes after kidney and kidney-pancreas transplantation.
P2860
Q21285083-59223DDE-C507-4AB0-A4E1-D969B302E660Q26764877-4D45E0E7-26D3-4290-8F36-530D9E02E836Q26773238-E113DD01-C841-424A-B61D-DAC363F63D0EQ26998832-A3532F5A-340F-4D61-B4C4-57CCCACD3B08Q27680381-F40E197E-9CAF-4EF6-A05C-B4275D91C626Q33567205-4F5928DA-731E-4473-A76D-D5605458E627Q33694700-68E65105-0662-48BA-B095-834BFD830592Q33930455-99F01036-8346-4571-95C1-8016DA6CE25AQ33987499-2494F9F6-AC37-49F4-AF51-835E9FBDE853Q34257069-87675AD2-9A41-4AF0-ABE1-F01AED5AECA4Q34337472-ED680420-648E-4F97-A612-07B73D65B1A4Q34576051-5A3A515E-EB7F-4046-AC4B-2B9FF70952CEQ34629128-1EA25D64-682E-48AC-944D-17075B046BE8Q34786760-D44BD9EA-B175-4804-B0F1-86D98047BBE5Q35006676-042856FD-42E1-41D6-B66D-2B72BBFE19E7Q35023405-7B93AE2A-6DF4-4F20-8E50-1154F88EB445Q35066928-DBA36C9E-EFA1-448A-9B47-D329CB389B7EQ35099077-500F1B28-D8AC-4BF7-9E1E-6D2C1EAFA7A1Q35986282-5278724A-19DE-4C4B-BAD4-3176D4166C98Q36002505-2B33E20F-35C4-4D93-9AFC-830FE8BD3B27Q36014205-629530FB-ADC9-46F5-9598-BFFB547608B2Q36026623-A7D5C8A9-FA7C-47CA-A1FC-AB6E2E174DABQ36102815-3D8F8D32-B86F-4EC5-BA50-E48511F461C8Q36315059-B05AF0BF-25D6-43E6-A266-8C28CC6CC868Q36400852-E5184B02-FA1F-4330-AC22-09AC7A8AE45EQ36464463-ECB1D018-91BE-4568-BBF8-77066AF1B3CDQ36537931-F82EE307-504C-4054-B016-BDDC7747CEC5Q36600128-0D780DBE-7447-46A5-87FB-8E29208D78E0Q36619243-4A63B4F9-70F3-4050-B67B-854CCCABC809Q36876460-107289C2-F05F-4418-83D2-9EFBBD6ED052Q36925928-C0F405F0-5507-4CD7-B72C-40D508A6770AQ36933028-D78AC91A-D90A-41DA-876A-4A450B037DCFQ36966167-118954E8-3BB3-4C57-A996-8921D3EE06BDQ37086685-AD5BCAD1-B2D3-4C60-9C6C-847F909F9E6EQ37102082-7BC400AD-3309-4A58-96AE-4B63177A770CQ37302119-4137E2F1-31D6-4DA5-B662-C61127257F2CQ37313492-92AB4F13-87AF-4844-8861-FD62797777C9Q37578274-A6E36D87-B777-45E0-900A-6E305E1DE9D0Q37583540-CF870288-CB28-4299-8D08-564717D65DE1Q37621575-9C88016B-E835-4E2C-8213-DB3D1557A4C5
P2860
Polyomavirus infection of renal allograft recipients: from latent infection to manifest disease.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Polyomavirus infection of rena ...... infection to manifest disease.
@ast
Polyomavirus infection of rena ...... infection to manifest disease.
@en
type
label
Polyomavirus infection of rena ...... infection to manifest disease.
@ast
Polyomavirus infection of rena ...... infection to manifest disease.
@en
prefLabel
Polyomavirus infection of rena ...... infection to manifest disease.
@ast
Polyomavirus infection of rena ...... infection to manifest disease.
@en
P2093
P1476
Polyomavirus infection of rena ...... infection to manifest disease
@en
P2093
Mihatsch MJ
Nickeleit V
P304
P577
1999-05-01T00:00:00Z